shares of vericel corp slid to a twoyear low of 1823 in wednesday after the company cut its 2022 revenue guidance and posted a wider thirdquarter loss than expected the stock fell to its lowest level since october 2020 minutes after the market opened before recovering to a more modest 15 loss at 1970 as of 1145 am et shares are down about 50 for the year the biopharmaceutical company said it now expects annual revenue between 164 million and 166 million compared with its prior forecast of 178 million to 189 million analysts polled by factset had been projecting revenue of 1783 million the cambridge massbased company also reported a thirdquarter net loss of 66 million or 14 cents a share compared with 49 million or 11 cents a share in the same quarter a year ago analysts had been expecting a loss of 10 cents a share according to factset